Total planned funding: $174,007,142
Allocations
Countries/Regions
India | $174,007,142 |
Organizational Types
Unknown | $69,315,998 |
NGO | $54,210,170 |
Own Agency | $27,433,090 |
University | $14,432,112 |
Multi-lateral Agency | $2,860,000 |
Private Contractor | $2,589,272 |
FBO | $1,600,000 |
Host Country Government Agency | $939,200 |
Other USG Agency | $627,300 |
Implementing Agency | $0 |
Program Areas
Governance and Systems | $58,175,271 |
Prevention | $47,410,778 |
Care | $27,274,619 |
Management and Operations | $20,077,769 |
Testing | $11,408,305 |
Treatment | $9,660,400 |
Budget Codes
OHSS: Health Systems Strengthening | $31,686,703 |
HVOP: Sexual Prevention: Other Sexual Prevention | $26,020,406 |
HVSI: Strategic Information | $21,363,655 |
HVMS: Management and Operations | $20,077,769 |
HBHC: Care: Adult Care and Support | $17,741,757 |
HVCT: Testing: HIV Testing and Counseling | $11,408,305 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $11,232,190 |
HTXS: Treatment: Adult Treatment | $9,176,905 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $5,175,472 |
HLAB: Laboratory Infrastructure | $5,124,913 |
HKID: Care: Orphans and Vulnerable Children | $5,059,992 |
HVTB: Care: TB/HIV | $3,719,530 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $3,673,057 |
HMBL: Biomedical Prevention: Blood Safety | $1,299,653 |
PDCS: Care: Pediatric Care and Support | $753,340 |
PDTX: Treatment: Pediatric Treatment | $460,018 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $10,000 |
Top Partner Programs
Not Available:
$68,691,509
Countries/Regions
USG Aggregated Agencies:
$16,865,023
Countries/Regions
FHI 360:
$16,829,182
Countries/Regions
Voluntary Health Services:
$11,460,000
Countries/Regions